February 2, 2026
Finance

Stock Futures Decline as Several Major Shares Slide in Early Trading

Xpeng Reports January Vehicle Deliveries Amid Broad Pre-Market Selloff in Key Stocks

Summary

U.S. stock futures began Monday's session lower, with the Dow futures slipping approximately 100 points. Notably, shares of Xpeng Inc sank following the release of its vehicle delivery figures for January 2026. Several other significant stocks, including Serina Therapeutics and Dragonfly Energy Holdings, also experienced declines in pre-market trading as various company announcements and regulatory developments influenced investor sentiment.

Key Points

U.S. stock futures declined with Dow futures dropping approximately 100 points early Monday.
Xpeng delivered 20,011 vehicles in January 2026 but its shares declined 5.6% in pre-market trading.
Serina Therapeutics filed a prospectus for resale of 7.7 million shares coinciding with a 27.3% drop in share price.
Dragonfly Energy announced an up to $50 million stock offering leading to a 19.4% pre-market share price fall.

In the early hours of Monday’s trading, U.S. stock futures showed a downward trend, signaling cautious market sentiment ahead of the regular session. The Dow futures fell by nearly 100 points, reflecting broad concerns affecting major equities. Among the notable movers was Xpeng Inc (NYSE: XPEV), whose American Depositary Receipts (ADRs) tumbled significantly after the company released its vehicle delivery statistics for January 2026.

Xpeng reported delivering 20,011 vehicles during the month of January. Despite this volume, the company’s shares experienced a sharp decline, dropping by approximately 5.6% to $16.97 in pre-market trading. This movement came as investors absorbed the delivery data, reflecting mixed reactions to the company’s operational figures.

Meanwhile, other prominent companies also encountered downward pressure in early trading. Phoenix Asia Holdings Ltd (NASDAQ: PHOE) saw its shares plummet by 55% to $59.91 following an extraordinary surge of nearly 997% on the preceding Friday. Such volatility highlights the speculative nature of the stock’s recent activity.

Serina Therapeutics Inc (NYSE: SER) shares fell sharply by 27.3%, settling at $2.35 during pre-market hours. The pharmaceutical company had just filed a prospectus for the resale of up to 7.7 million shares of common stock by selling stockholders, a development that potentially raised concerns about dilution among investors.

Similarly, Dragonfly Energy Holdings Corp (NASDAQ: DFLI) experienced a 19.4% decline in its pre-market share price, dropping to $2.58. The energy firm announced a new “at-the-market” stock offering targeting up to $50 million, which may contribute to the downward pressure on its shares as markets price in the impact of fresh equity issuance.

Pharming Group N.V. ADS (NASDAQ: PHAR) faced a 13.5% decrease in pre-market trading to $17.62. The company received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) concerning the supplemental New Drug Application (sNDA) for Joenja® (leniolisib), intended for children aged 4 to 11 suffering from Activated Phosphoinositide 3-kinase Delta Syndrome (APDS). Such regulatory setbacks commonly weigh on pharmaceutical stocks due to uncertainties around product approval timelines.

Additional stocks also moved lower amid the broader market downturn. Terra Innovatum Global (NASDAQ: NKLR) declined by 11.5% to $4.41, while Armada Acquisition Corp II (NASDAQ: XRPN) settled 11.1% lower at $9.11. Bitmine Immersion Technologies Inc (NYSE: BMNR) decreased by 10.5% to $22.46. Adlai Nortye Ltd (NASDAQ: ANL) dropped 10.4% to $9.52, following a substantial 63% gain on the previous trading day.

Celcuity Inc (NASDAQ: CELC) saw a 9.6% decrease, with shares at $98.88. Likewise, Strategy Inc (NASDAQ: MSTR) fell 7.3% to $138.80, and Hut 8 Corp (NASDAQ: HUT) slid 6.2% to $52.36, movements coinciding with recent declines in Bitcoin’s value, reflecting their connection to cryptocurrency markets.

Finally, Albemarle Corp (NYSE: ALB), a name often associated with the materials and specialty chemicals sectors, declined by 5.8%, ending the pre-market session at $160.68. The company’s performance fits into the general theme of investor caution that characterized the start of the trading day.


Key Points:

  • U.S. stock futures showed declines early Monday, with Dow futures down roughly 100 points.
  • Xpeng Inc reported January vehicle deliveries totaling 20,011 units, yet shares dropped 5.6% in pre-market trading.
  • Serina Therapeutics filed a prospectus for the resale of up to 7.7 million shares, coinciding with a 27.3% share price decrease.
  • Dragonfly Energy launched an up to $50 million at-the-market offering, contributing to a nearly 20% fall in its shares pre-market.

Risks and Uncertainties:

  • Regulatory challenges such as the FDA's Complete Response Letter to Pharming Group introduce unpredictability regarding drug approvals and future sales.
  • Equity dilution potential from sizable stock offerings or share resales, as seen with Serina Therapeutics and Dragonfly Energy, may weigh on share values.
  • Volatility in cryptocurrency markets impacts correlated stocks like Strategy Inc and Hut 8 Corp, augmenting share price risks.
  • Investor reactions to company performance announcements, such as vehicle delivery figures by Xpeng, can lead to significant share price fluctuations.
Risks
  • FDA Complete Response Letter to Pharming Group creates regulatory uncertainty.
  • Potential dilution from Serina Therapeutics' large resale of shares could impact share value.
  • Dragonfly Energy's at-the-market offering may put downward pressure on its stock price.
  • Cryptocurrency price declines affect related stocks like Strategy Inc and Hut 8 Corp, increasing volatility.
Disclosure
Education only / not financial advice
Search Articles
Category
Finance

Financial News

Ticker Sentiment
XPEV - negative PHOE - negative SER - negative DFLI - negative PHAR - negative
Related Articles
Treasury Secretary Highlights Urgency for Crypto Regulatory Clarity Amidst Coinbase Opposition

In light of recent fluctuations in cryptocurrency markets, U.S. Treasury Secretary Scott Bessent emp...

Figma Shares Climb as Analysts Predict Software Sector Recovery

Figma Inc's stock experienced a notable uptick amid a broader rally in software equities. Analysts a...

SoFi Shares Slip Slightly Despite Strong Q4 Earnings and Bullish Outlook

SoFi Technologies Inc’s stock saw a minor decline Tuesday afternoon following a period of heighten...

Becton Dickinson Faces Market Headwinds Amid Transition and Revised Earnings Projections

Becton Dickinson & Co. posted first-quarter earnings above analyst expectations but trimmed its fisc...

Interactive Brokers Broadens Crypto Trading with New Coinbase Derivatives Launch

Interactive Brokers has introduced new nano-sized Bitcoin and Ethereum futures through a partnership...

UniFirst Shares Climb Amid Renewed Acquisition Conversations with Cintas

UniFirst Corporation's stock has experienced a significant rise following reports that it is activel...